CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion

Journal of Clinical Pathology - Molecular Pathology

Volumn 55, Issue 2, 2002, Pages 110-120

  Gallagher, N J ^a   Eliopoulos, A G ^a   Agathangelo, A ^a   Oates, J ^b   Crocker, J ^b   Young, L S ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; JANUS KINASE; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CARCINOMA CELL; CONTROLLED STUDY; CYTOKINE RELEASE; ELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; OVARY CARCINOMA; PHOSPHORYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; APOPTOSIS; CARCINOMA; CD40 LIGAND; CELL DIVISION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; INTERLEUKIN-8; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OVARIAN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036215615     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.55.2.110     Document Type: Article

References (62)

1. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation
2. CD40 and CD154 in cell-mediated immunity
3. Help for cytotoxic T cell responses is mediated by CD40 signalling
4. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
5. CD40 ligand and its role in X-linked hyper-IgM syndrome
6. Abnormal CD40-mediated activation pathway in B lymphocytes from patients with hyper-IgM syndrome and normal CD40 ligand expression
7. The immune responses in CD40 deficient mice: Impaired immunoglobulin class switching and germinal center formation
8. Humoral immune responses in CD40 ligand-deficient mice
9. CD40 signaling pathway: Anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein
10. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cg2
11. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activated protein kinases
12. Differential activation of the ERK, JNK and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor
13. Characterization of CD40 signaling determinants regulating nuclear factor-κB activation in B lymphocytes
14. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes
15. Involvement of CRAF1, a relative of TRAF, in CD40 signaling
16. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling
17. Identification of TRAF6, a novel tumour necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region
18. Two differently regulated nuclear factor kB activation pathways triggered by the cytoplasmic tail of CD40
19. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1
20. Signal transduction through NF-κb
21. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signalling along a Ras-independent pathway
22. Activation of stress-activated protein kinase/cJun N-terminal kinase, but not NF-κB, by the tumor necrosis factor (TNF) receptor 1 through a TNF receptor-associated factor 2- and germinal center kinase related-dependent pathway
23. ASK1 is essential for JNK/SAPK activation by TRAF2
24. Expression of functional CD40 by vascular endothelial cells
25. CD40 expressed on thymic epithelial cells provides costimulation for proliferation but not apoptosis of human thymocytes
26. CD40 and epithelial cells: Across the great divide
27. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: Involvement of TRAF3 as a common mediator
28. CD40 is functionally expressed on human keratinocytes
29. CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation
30. Adenoviral delivery of B7.1 (CD80) increases the immunogenicity of human ovarian and cervical carcinoma cells
31. Rapid colorimetric assay for cellular growth and survival: Application of proliferation and cytotoxicity assay
32. The PGP specific combination Syto(R) 16/PSC833 detects early apoptosis in CD34 positive progenitor cells
33. Tumor necrosis factor-induced apoptosis is mediated by a crmA-sensitive cell death pathway
34. Resistance to Fas-mediated apoptosis in human hepatoma-cells
35. Constitutive production of interleukin-6 by ovarian-cancer cell lines and by primary ovarian tumor cultures
36. Taxol-dependent transcriptional activation of IL-8 expression in a subset of human ovarian cancer
37. Tumor necrosis factor-α and interleukin-6 are differently expressed by fresh human cancerous ovarian tissue and primary cell lines
38. A novel function of CD40: Induction of cell death in transformed cells
39. CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumour necrosis factor family
40. Long-term human B-cell lines dependent on interleukin-4 and antibody to CD40
41. Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand
42. Arrest of B lymphocyte terminal differentiation by CD40 signaling: Mechanism for lack of antibody-secreting cells in germinal centers
43. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1
44. Inhibition of B-cell lymphoma growth by CD40 stimulation
45. Human epidermal keratinocytes are induced to secrete interleukin 6 and co-stimulate T-lymphocytes
46. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors
47. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor α-dependent angiogenesis
48. Entamoeba histolytica stimulates interleukin 8 from human colonic epithelial cells without parasite-enterocyte contact
49. Activation of IL-8 gene expression by Helicobacter pylori is regulated by transcriptional factor nuclear factor κB in gastric epithelial cells
50. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40
51. Phosphorylation of human IκBα on serine-32 and serine-36 controls IκBα proteolysis and NF-κB activation in response to diverse stimuli
52. DNA-dependent protein kinase phosphorylation of IκBα and IκBβ regulates NF-κB DNA binding properties
53. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
54. Signal transduction - IκB kinases: Kinsmen with different crafts
55. Defective IκBα in Hodgkin cell lines with constitutively active NF-κB
56. Oct-1 and CCAAT/enhancer-binding protein (C/EBP) bind to overlapping elements within the interleukin 8 promoter
57. Activation of the p38 MAPK pathway by Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) co-regulates interleukin-6 and interleukin-8 production
58. The jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitises tumor cells to cisplatin
59. Paclitaxel (Taxol)-induced gene expression and cell death are both mediated by the activation of c-jun NH2-terminal kinase cJNK (SAPK)
60. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and -independent pathways in ovarian cancer cells
61. Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand
62. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells